Key Takeaways LMND's net investment income has risen 16% YTD to $28.6M, following a 38% jump to $34M in 2024.Growth was fueled by diversification into higher-yield investments across its fixed-income portfolio.Steady investment returns support LMND's scaling efforts and help offset underwriting volatility.Lemonade Inc.’s (LMND) top line, like any other insurer, has net investment income as an important component, complementing premium revenues as well as commission and other income.LMND’s net investment inc ...

Core Insights - Vireo Growth Inc. has entered into a licensing agreement with Curio Wellness to bring Curio's Best Self Collection to the New York cannabis market [1][2] - The partnership allows Vireo to manufacture and distribute Curio's full range of products, including topicals, tablets, chews, and vapes, utilizing Vireo's existing infrastructure in New York [2][3] - This collaboration is designed to facilitate Curio's expansion into New York without significant new investment, while Vireo enhances its product offerings with established, high-demand items [2][4] Company Profiles - Vireo Growth Inc. is a multi-state, vertically-integrated cannabis operator founded in 2014, focusing on disciplined and strategic growth within the cannabis industry [6] - Curio Wellness is a cGMP-certified cannabis company known for its innovative health and wellness products, emphasizing quality and compliance with Good Manufacturing Practices [5][6] Market Strategy - The first Curio-branded products are expected to launch in licensed New York dispensaries in Q4 2025, indicating a strategic entry into a promising market [4] - The partnership is viewed as a strong strategic fit for both companies, aiming to deliver premium offerings to health-conscious cannabis consumers [3][4]